24
Participants
Start Date
May 23, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
February 28, 2027
Drug: B10 L-BPA Injection
"The investigational product is B10 L-BPA Injection, is a boron-containing compound in which 10B replaces a position on L-phenylalanine at the para position with dihydroxyboron.~This single arm of the study is designed to evaluate the therapeutic efficacy of BNCT, wherein patients receive B10 L-BPA administration followed by neutron irradiation."
NOT_YET_RECRUITING
China Medical University Hospital, Taichung
RECRUITING
Taipei Veterans General Hsopital, Taipei,, Taipei
Heron Neutron Medical Corp.
INDUSTRY
China Medical University Hospital
OTHER